Pre-earnings options volume in Eledon Pharmaceuticals (ELDN) is normal with puts leading calls 4:3. Implied volatility suggests the market is anticipating a move near 8.0%, or 17c, after results are released. Median move over the past eight quarters is 2.1%.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELDN:
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
- Eledon Pharmaceuticals’ Tegoprubart: Promising Safety Profile and Market Potential Despite eGFR Setback
- Why Is Eledon Pharmaceuticals Stock (ELDN) Down 50% Today?
- Eledon Pharmaceuticals Reports Promising Phase 2 Trial Results
- Eledon Pharmaceuticals Advances Kidney Transplant Study with Tegoprubart